CORTEXYME INC (CRTX)

US22053A1079 - Common Stock

1.95  +0.05 (+2.63%)

After market: 1.99 +0.04 (+2.05%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2022-3-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
88.87M90.32M78.89M39.17M12.12M
Research and Development
56.73M60.80M61.31M30.21M10.09M
Selling, General, and Administrative Expenses
32.14M29.52M17.59M8.95M2.03M
Operating Income
-88.87M-90.32M-78.89M-39.17M-12.12M
Interest Income/Expense
465.00K620.00K2.04M2.19M-360.00K
Other Income/Expense
-98.00K-247.00KN/AN/AN/A
Income Before Taxes
-88.50M-89.94M-76.85M-36.98M-12.48M
Income Tax
N/AN/AN/AN/A0.00
Net Income
-88.50M-89.94M-76.85M-36.98M-12.48M
EBITDA
-88.58M-89.97M-78.56M-38.98M-12.07M
 
Per Share Data
EPS Diluted Total Ops
-2.96-3.03-2.63-1.94-0.48
Non GAAP EPS
-2.97-3.03-2.63-2.90N/A
 
Statistics

All data in USD

Charts